Skip to main content
SpringerLink
Log in

From Laboratory to Clinic

The Story of CAM PA TH-1

  • Protocol
Diagnostic and Therapeutic Antibodies

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 40))

Abstract

In 1890 it was shown that resistance to diphtheria toxin could be transferred from one animal to another by transfer of serum (1). From this discovery, passive antibody therapy was developed as an effective treatment for infectious diseases and for neutralization of toxins, and continues to be used to this day. Meanwhile, there have been continued efforts to use antibodies for cancer therapy, starting with the pioneering work of Hericourt and Richet in 1895 (2), which was the forerunner of the “magic bullet” concept. However, all of the early work on tumor therapy led ultimately to disappointment (3). The problems were readily acknowledged, i.e., lack of specificity and reproducibility, lack of purity, and the xenogeneic immune response. Developments over the past 20 years, as described throughout this book, have effectively overcome all of these technical problems, often in very ingenious ways. The difficulty we have now is different. There are just too many potential new antibody-based treatments for them all to be properly evaluated in the clinic. Many will still fail because of factors that are hard to predict from experiments: unexpected toxicity, biological heterogeneity of the target disease, or lack of access to the appropriate tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. von Behring, E. and Kitasato, S. (1890) Dtsch. Med. Wochenshe. 16, 1113–1114.

    Google Scholar 

  2. Hericourt, J. and Richet, C. (1895) “Physologie Pathologique”-de la serotherapie dans la traitement du cancer. Comptes Rendus Hebd. Seanc. Acad. Sci.121, 567.

    Google Scholar 

  3. Currie, G. A. (1972) Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer. Br. J. Cancer26, 141–153.

    CAS  PubMed  Google Scholar 

  4. Prentice, H. G., Blacklock, H. A., Janossy, G., Bradstock, K. F., Skeggs, D., Goldstein, G., and Hoffbrand, A. V. (1982) Use of anti-T cell monoclonal antibody OKT3 to prevent acute graft versus host disease in allogeneic bone marrow transplantation for acute leukemia. Lancet1, 700–703.

    CAS  Google Scholar 

  5. Filipovitch, A. H., Vallera, D. A., Youle, R. J., Haake, R., Blazar, B. R., Arthur, D., Neville, Ramsay, N. K., McGlave, P., and Kersey, J. H. (1987) Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histo-compatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow. Transplantation44, 62–69.

    Google Scholar 

  6. Clark, M., Cobbold, S., Hale, G., and Waldmann, H. (1983) Advantages of rat monoclonal antibodies. Immunol. Today4, 100–101.

    CAS  PubMed  Google Scholar 

  7. Hale, G., Bright, S., Chumbley, G., Hoang, T., Metcalf, D., Munro, A. J., and Waldmann, H. (1983) Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood62, 873–882. 263

    CAS  PubMed  Google Scholar 

  8. Hale, G., Hoang, T., Prospero, T., Watt, S. M., and Waldmann, H. (1983) Removal of T cells from bone marrow for transplantation: comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes. Mol. Biol. Med.1, 305–319.

    CAS  PubMed  Google Scholar 

  9. Hale, G., Swirsky, D. M., Hayhoe, F. G. J., and Waldmann, H. (1983) Effects of monoclonal anti-lymphocyte antibodies in vivo in monkeys and humans. Mol. Biol. Med.1, 321–334.

    CAS  PubMed  Google Scholar 

  10. Waldmann, H., Or, R., Hale, G., Weiss, L., Cividalli, G., Samuel, S., Manor, D., Brautbar, C., Polliack, A., Rachmilewitz, E. A., and Slavin, S. (1984) Elimination of graft versus host disease by in vitro depletion of alloreactive lymphocytes using a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet2, 483–486.

    CAS  PubMed  Google Scholar 

  11. Heit, W., Bunjes, D., Weisneth, M., Schmeiser, T., Arnold, R., Hale, G., Waldmann, H., and Heimpel, H. (1986) Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute GvHD in allogeneic bone marrow transplantation. Br. J. Haematol.64, 479–486.

    CAS  PubMed  Google Scholar 

  12. Goldman, J. M., Apperley, J. F., Jones, L., Marcus, R., Goolden, A. W. G., Batchelor, R., Hale, G., Waldmann, H., Reid, C. D., Hows, J., Gordon-Smith, E., Catovsky, D., and Galton, D. A. G. (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. New Engl. J. Med.314, 202–207.

    CAS  PubMed  Google Scholar 

  13. Hale, G., Cobbold, S., and Waldmann, H. (1988) T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation. Transplantation45, 753–759.

    CAS  PubMed  Google Scholar 

  14. Cobbold, S. P., Thierfelder, S., and Waldmann, H. (1983) Immunosuppression with monoclonal antibodies: a model to determine the rules for effective serotherapy. Mol. Biol. Med.1, 285–304.

    CAS  PubMed  Google Scholar 

  15. Cobbold, S. P., Martin, G., and Waldmann, H. (1986) Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection: the depletion of T-cell subsets in vitro and in vivo. Transplantation42, 239–247.

    CAS  PubMed  Google Scholar 

  16. Hale, G., Clark, M., and Waldmann, H. (1985) Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependant cell-mediated cytotoxicity with human lymphocytes. J. Immunol.134, 3056–3061.

    CAS  PubMed  Google Scholar 

  17. Bruggemann, M., Free, J., Diamond, A., Howard, J., Cobbold, S. P., and Waldmann, H. (1986) Immunoglobulin heavy chain locus of the rat: striking homology to mouse antibody genes. Proc. Natl. Acad. Sci. USA83, 6075–6079.

    CAS  PubMed  Google Scholar 

  18. Hale, G., Cobbold, S. P., Waldmann, H., Easter, G., Matejtschuk, P., and Coombs, R. R. A. (1987) Isolation of low-frequency class-switch variants from rat hybrid myelomas. J. Immunol. Methods103, 59–67.

    CAS  Google Scholar 

  19. Dyer, M. J. S., Hale, G., Hayhoe, F. G. J., and Waldmann, H. (1989) Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood73, 1431–1439.

    CAS  PubMed  Google Scholar 

  20. Neuberger, M. S., Williams, G. T., Mitchell, E. B., Jouhal, S. S., Flanagan, J. G., and Rabbitts, T. N. (1985) A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature314, 268–270. 264

    CAS  PubMed  Google Scholar 

  21. Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., and Winter, G. (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature321, 522–525.

    CAS  PubMed  Google Scholar 

  22. Friend, P. J., Waldmann, H., Hale, G., Cobbold, S., Rebello, P., Thiru, S., Jamieson, N. V., Johnston, P. S., and Calne, R. Y. (1991) Reversal of allograft rejection using the monoclonal antibody CAMPATH-1G. Transplant. Proc.23, 1390–1392.

    CAS  PubMed  Google Scholar 

  23. Riechmann, L., Clark, M., Waldmann, H., and Winter, G. (1988) Reshaping human antibodies for therapy. Nature332, 323–327.

    CAS  PubMed  Google Scholar 

  24. Bruggemann, M., Williams, G. T., Bindon, C. I., Clark, M. R., Walker, M. R., Jefferies, R., Waldmann, H., and Neuberger, M. S. (1987) Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med.166, 1351–1361.

    CAS  PubMed  Google Scholar 

  25. Hale, G., Dyer, M. J. S., Clark, M. R., Phillips, J. M., Marcus, R., Riechmann, L., Winter, G., and Waldmann, H. (1988) Remission induction in non-Hodgkin lym-phoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet2, 1394–1399.

    CAS  PubMed  Google Scholar 

  26. Hale, G. (1993) Small scale production of novel therapeutic products: a new challenge for the transfusion service? (editorial) Transfus. Med.3, 1–5.

    CAS  PubMed  Google Scholar 

  27. Lockwood, C. M., Thiru, S., Isaacs, J. D., Hale, G., and Waldmann, H. (1993) Humanised monoclonal antibody treatment for intractable systemic vasculitis. Lancet341, 1620–1622.

    CAS  PubMed  Google Scholar 

  28. Lockwood, C. M., Thiru, S., Stewart, S., Hale, G., Isaacs, J. D., Wraight, P., Elliott, J., and Waldmann, H. (1996) Treatment of refractory Wegener’s granulo-matosis with humanised monoclonal antibodies. Q. J. Med.89, 903–912.

    CAS  Google Scholar 

  29. Isaacs, J. D., Watts, R. A., Hazleman, B. L., Hale, G., Keogan, M. T., Cobbold, S. P., and Waldmann, H. (1992) Humanised monclonal antibody therapy for rheumatoid arthritis. Lancet340, 748–752.

    CAS  PubMed  Google Scholar 

  30. Brett, S., Baxter, G., Cooper, H., Johnston, J. M., Tite, J., and Rapson, N. (1996) Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology88, 13–19.

    CAS  PubMed  Google Scholar 

  31. Jendro, M. C., Ganten, T., Matteson, E. L., Weyand, C. M., and Goronzy, J. J. (1995) Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheuamtoid arthritis. Arthritis Rheum.38, 1242–1251.

    CAS  Google Scholar 

  32. Pawson, R., Dyer, M. J. S., Barge, R., Matutes, E., Thornton, P. D., Emmett, E., Kluin-Nelemans, J. C., Fibbe, W. E., Willemze, R., and Catovsky, D. (1997) Treatment of T-cell prolymphocytic leukaemia with human CD52 antibody. J. Clin. Oncol.15, 2667–2672.

    CAS  Google Scholar 

  33. Jacobs, P. Wood, L., Fullard, L., Waldmann, H., and Hale, G. (1993) T-cell depletion by exposure to CAMPATH-1G in vitro prevents graft-versus-host disease. Bone Marrow Transplant.13, 763–769.

    Google Scholar 

  34. Hale, G. and Waldmann, H. for CAMPATH users (1994) Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with 265 CAMPATH-1 antibodies. Results of matched sibling transplants for malignant diseases. Bone Marrow Transplant.13, 597–611.

    CAS  PubMed  Google Scholar 

  35. Hale, G. and Waldmann, H. for CAMPATH users (1994) CAMPATH-1 monoclonal antibodies in bone marrow transplantation. Hematotherapy3, 15–31.

    Google Scholar 

  36. Newman, D. K., Isaacs, J. D., Watson, P. G., Meyer, P. A., Hale, G., and Waldmann, H. (1995) Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H. Eye9, 564–569.

    Google Scholar 

  37. Isaacs, J. D., Dick, A. D., Haynes, R., Watson, P., Forrester, J. V., Myer, P., Hale, G., and Waldmann, H. (1996) Monoclonal antibody therapy of chronic intraocular inflammation using CAMPATH-1H. Br. J. Ophthalmol.79, 1054,1055.

    Google Scholar 

  38. Isaacs, J. D., Hazleman, B. L., Chakravarty, K., Grant, J. W., Hale, G., and Waldmann, H. (1996) Monoclonal antibody therapy of diffuse cutaneous sclero-derma with CAMPATH-1H. J. Rheumatol.23, 1103–1106.

    CAS  Google Scholar 

  39. Lim, S. H., Hale, G., Marcus, R. E., Waldmann, H., and Baglin, T. P. (1993) CAMPATH-1 MoAb in the treatment of refractory autoimmune thrombocy-topenic purpura Br. J. Haematol.84, 542–544.

    CAS  Google Scholar 

  40. Killick, S. B., Marsh, J. C. W., Hale, G., Waldmann, H., Kelly, S. J., and Gordon-Smith, E. C. (1997) Sustained remission of severe resistant auto-immune neutro-penia with Campath-1H. Br. J. Haematol.97, 306–308.

    CAS  PubMed  Google Scholar 

  41. Moreau, T., Thorpe, J., Miller, D., Moseley, I., Hale, G., Waldmann, H., Clayton, D., Wing, M., Scolding, N., and Compston, A. (1994) Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet344, 298–301.

    CAS  PubMed  Google Scholar 

  42. Chatenoud, L., Ferran, C., Legendre, C., Thouard, I., Merite, S., Reuter, A., Gevaert, Y., Kreis, H., Franchimont, P., and Bach, J.-F. (1990) In vivo cell activation following OKT3 adminstration. Systematic cytokine release and modulation by corticosteroids. Transplantation49, 697–702.

    CAS  PubMed  Google Scholar 

  43. Moreau, T., Coles, A., Wing, M. G., Isaacs, J., Hale, G., Waldmann, H., and Compston, A. (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis Brain119, 225–237.

    PubMed  Google Scholar 

  44. Coles, A. J., Wing, M. G., Smith, S. I., Corradu, F., Greer, S., Taylor, C. J., Weetman, A. P., Hale, G., Chatterjee, V. K., Waldmann, H., and Compston, A. (1998) Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet354, 1691–1696.

    Google Scholar 

  45. Coles, A. J., Molyneux, P., Wing, M. G., Paolillo, A., Davie, C. M., Hale, G., Miller, D., Waldmann, H., and Compston, A. (1998) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol.46, 296–304.

    Google Scholar 

  46. Compston, A. (1994) Future prospects for the management of multiple sclerosis. Ann Neurol.36, S146–S150.

    PubMed  Google Scholar 

  47. Bindon, C. I., Hale, G., and Waldmann, H. (1988) Importance of antigen specificity for complement mediated lysis by monoclonal antibodies. Eur. J. Immunol.18, 1507–1514.

    CAS  PubMed  Google Scholar 

  48. Hale, G., Xia, M.-Q., Tighe, H. P., Dyer, M. J. S., and Waldmann, H. (1990) The CAMPATH-1 antigen (CDw52). Tissue Antigens35, 118–127.

    CAS  PubMed  Google Scholar 

  49. Xia, M.-Q., Tone, M., Packman, L., Hale, G., and Waldmann, H. (1991) Characterization of the CAMPATH-1 antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur. J. Immunol.21, 1677–1684.

    CAS  PubMed  Google Scholar 

  50. Xia, M.-Q., Hale, G., Lifely, M. R., Ferguson, M. J., Campbell, D., Packman, L., and Waldmann, H. (1993) Structure of the CAMPATH-1 antigen, a GPI-anchored glycoprotein which is an exceptionally good target for complement lysis. Biochem. J.293, 633–640.

    CAS  PubMed  Google Scholar 

  51. Treumann, A., Lifely, R., Schneider, P., and Ferguson, M. A. J. (1995) Primary structure of CD52. J. Biol. Chem.270, 6088–6099.

    CAS  PubMed  Google Scholar 

  52. Hale, G., Rye, P. D., Warford, A., Lauder, I., and Brito-Babapulle, A. (1993) The GPI-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa. J. Reprod. Immunol.23, 189–205.

    CAS  PubMed  Google Scholar 

  53. Kirchhoff, C., Krull, N., Pera, I., and Ivell, R. (1992) A major mRNA of the human epididymal principal cells, HE5, encodes the leucocyte differentiation CDw52 antigen peptide backbone. Mol. Repr. Dev.34, 11–15.

    Google Scholar 

  54. Diekman, A. B., Westbrook-Case, A., Naaby-Hansen, S., Klotz, K. L., Flickinger, C. J., and Herr, J. C. (1997) Biochemical characterization of sperm agglutination antigen-1, a human sperm surface antigen implicated in gamete interactions. Biol. Reprod.57, 1136–1145.

    CAS  PubMed  Google Scholar 

  55. Gilliland, L. K., Walsh, L. A., Frewin, M. R., Wise, M., Tone, M., Hale, G., Kioussis, D., and Waldmann, H. (1998) Elimination of the immunogenicity of therapeutic antibodies. J. Immunol.162, 3663–3671.

    Google Scholar 

  56. Calne, R., Moffatt, S. D., Friend, P. J., Jamieson, N. V., Bradley, J. A., Hale, G., Firth, J., Bradley, J., Smith, K. G., and Waldmann, H. (1999) CAMPATH-1H allows low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Transplantation68, 1613–1616.

    CAS  PubMed  Google Scholar 

  57. Dyer, M. J. S., Hale, G., Marcus, R., and Waldmann, H. (1990) Remission induction in patients with lymphoid malignancies using unconjugated CAMPATH-1 monoclonal antibodies. Leukemia Lymphoma2, 179–193.

    CAS  PubMed  Google Scholar 

  58. Reuter, H., Wraight, E. P., Qasim, F. J., and Lockwood, C. M. (1995) Management of vasculitis: the contribution of scintigraphic imaging to the evaluation of disease activity and classification. Q. J. Med.88, 509–516.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sir William Dunn School of Pathology, Oxford University, Oxford, UK

    Geoff Hale & Herman Waldmann

Authors
  1. Geoff Hale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Herman Waldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Andrew J. T. George

  2. Department of Pharmacology, University College, London, UK

    Catherine E. Urch

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Hale, G., Waldmann, H. (2000). From Laboratory to Clinic. In: George, A.J.T., Urch, C.E. (eds) Diagnostic and Therapeutic Antibodies. Methods in Molecular Medicine, vol 40. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-076-4:243

Download citation

  • DOI: https://doi.org/10.1385/1-59259-076-4:243

  • Publisher Name: Humana, Totowa, NJ

  • Print ISBN: 978-0-89603-798-4

  • Online ISBN: 978-1-59259-076-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation